Our world has changed. The need for effective infection control and protection is now clear and paramount. To continue to respond to this need, the British Medical Group delivers a range of established and emerging technologies in medical devices and antimicrobial technologies that will help PROECT your world.

Through Chemical Intelligence, we have developed and patented a unique, low cost antibacterial and antiviral treatment for global infection control. This innovation launched in 2018 on antimicrobial examination gloves, and in a surgical mask in 2021.

We are also open to new partners to develop this and follow-on technologies for other high volume, low cost uses such as surgical gowns, drapes, respirator masks and all associated packaging.

BMG has deep expertise in the Technical, Regulatory, Microbiological, Intellectual Property and Commercial requirements to successfully innovate in the healthcare space.

We are committed to continue delivering innovative, low cost solutions that help our clients deliver their own mission safely.

Sanitas Healthcare commercialises our innovations under our own PROTECT™ brand